Thromboprophylaxis with a low-dose direct-acting oral anticoagulant was associated with lower incidences of cancer-associated thrombosis and bleeding compared with placebo.
Medical and ethical considerations are discussed, including in cases of conflict between parent, child.
Patients’ survey responses ranged from the garments cause discomfort to they alleviate discomfort. Some responses indicated patients face a possible trade-off between comfort and protection in finding the optimal support garment.
Investigators at UCSD sought to create a tool to help clinicians predict patients’ risk of persistent opioid use after treatment.
Prophylactic antibiotics trended toward reducing infection risk at 3 months if given in first 2 to 3 months after MM diagnosis; however, it had no effect on mortality rates.
A review of the Pennsylvania Medical Marijuana Program defined the symptom profile of patients with breast cancer who sought to use medical marijuana.
Data from an ongoing trial of luspatercept, an erythroid maturation agent, in patients with myelofibrosis and anemia shows promise of clinically significant activity with low level of grade 3/4 adverse effects.
Researchers sought to determine if corticosteroids can be used to effectively manage CRS in patients undergoing CAR-T therapy without negatively influencing outcomes.
In a safety expansion of the ZUMA-1 study, researchers found that steroids may reduce incidence of CRS and neurologic events associated with CAR-T therapy in patients with relapsed/refractory large B cell lymphoma.
The TEAMM trial sought to assess time to first febrile episode or death from all causes in patients with newly diagnosed myeloma who received antibiotic prophylaxis vs those who did not.
